Literature DB >> 28319291

High risk of overdose death following release from prison: variations in mortality during a 15-year observation period.

Anne Bukten1,2, Marianne Riksheim Stavseth1, Svetlana Skurtveit1,3, Aage Tverdal3, John Strang4, Thomas Clausen1.   

Abstract

BACKGROUND AND AIMS: The time post-release from prison involves elevated mortality, especially overdose deaths. Variations in overdose mortality both by time since release from prison and time of release has not been investigated sufficiently. Our aims were to estimate and compare overdose death rates at time intervals after prison release and to estimate the effect on overdose death rates over calendar time. DESIGN, SETTING, PARTICIPANTS, MEASUREMENTS: This 15-year cohort study includes all individuals (n = 91 090) released from prison (1 January 2000 to 31 December 2014) obtained from the Norwegian prison registry, linked to the Norwegian Cause of Death Registry (2000-14). All-cause and cause-specific mortality were examined during different time-periods following release: first week, second week, 3-4 weeks and 2-6 months, and by three different time intervals of release. We calculated crude mortality rates (CMRs) per 1000 person-years and estimated incidence rate ratios (IRR) by Poisson regression analysis adjusting for time intervals after prison release, release periods and time spent in prison.
FINDINGS: Overdose deaths accounted for 85% (n = 123) of all deaths during the first week following release (n = 145), with a peak during the 2 days immediately following release. Compared with week 1, the risk of overdose death was more than halved during week 2 [IRR = 0.43; 95% confidence interval (CI) = 0.31-0.59] and reduced to one-fifth in weeks 3-4 (IRR = 0.22; 95% CI = 0.16-0.31). The risk of overdose mortality during the first 6 months post-release was almost twofold higher in 2000-04 compared with 2005-09 (IRR = 0.53; 95% CI = 0.43-0.65) and 2010-14 (IRR = 0.47; 95% CI = 0.37-0.59). The risk of overdose death was highest for those incarcerated for 3-12 months compared with those who were incarcerated for shorter or longer periods, and recidivism was associated with risk of overdose death.
CONCLUSIONS: There is an elevated risk of death from drug overdose among individuals released from Norwegian prisons, peaking in the first week. The risk has reduced since 2000-04, but is greatest for those serving 3-12 months compared with shorter or longer periods.
© 2017 Society for the Study of Addiction.

Entities:  

Keywords:  Criminal justice; drug use; mortality; opioid maintenance treatment; opioids; overdose; prison; prison release

Mesh:

Year:  2017        PMID: 28319291     DOI: 10.1111/add.13803

Source DB:  PubMed          Journal:  Addiction        ISSN: 0965-2140            Impact factor:   6.526


  34 in total

1.  Prevalent Misconceptions About Opioid Use Disorders in the United States Produce Failed Policy and Public Health Responses.

Authors:  Robert Heimer; Kathryn Hawk; Sten H Vermund
Journal:  Clin Infect Dis       Date:  2019-07-18       Impact factor: 9.079

2.  Estimating the impact of wide scale uptake of screening and medications for opioid use disorder in US prisons and jails.

Authors:  Alexandria Macmadu; William C Goedel; Joëlla W Adams; Lauren Brinkley-Rubinstein; Traci C Green; Jennifer G Clarke; Rosemarie A Martin; Josiah D Rich; Brandon D L Marshall
Journal:  Drug Alcohol Depend       Date:  2020-01-18       Impact factor: 4.492

3.  Impact of methadone treatment initiated in jail on subsequent arrest.

Authors:  Sharon M Kelly; Robert P Schwartz; Kevin E O'Grady; Shannon G Mitchell; Tiffany Duren; Anjalee Sharma; Jerome H Jaffe
Journal:  J Subst Abuse Treat       Date:  2020-04-04

4.  Drug fatalities and treatment fatalism: Complicating the ageing cohort theory.

Authors:  Fay Dennis
Journal:  Sociol Health Illn       Date:  2021-05-06

5.  Application of Distributed Agent-based Modeling to Investigate Opioid Use Outcomes in Justice Involved Populations.

Authors:  Eric Tatara; John Schneider; Madeline Quasebarth; Nicholson Collier; Harold Pollack; Basmattee Boodram; Sam Friedman; Elizabeth Salisbury-Afshar; Mary Ellen Mackesy-Amiti; Jonathan Ozik
Journal:  IEEE Int Symp Parallel Distrib Process Workshops Phd Forum       Date:  2021-06-24

6.  Cost-effectiveness of extended-release injectable naltrexone among incarcerated persons with opioid use disorder before release from prison versus after release.

Authors:  Ali Jalali; Philip J Jeng; Daniel Polsky; Sabrina Poole; Yi-Chien Ku; George E Woody; Sean M Murphy
Journal:  J Subst Abuse Treat       Date:  2022-07-02

7.  The impact of the opioid crisis on U.S. state prison systems.

Authors:  Christy K Scott; Michael L Dennis; Christine E Grella; Allison F Mischel; John Carnevale
Journal:  Health Justice       Date:  2021-07-24

8.  Circumstances of overdose among street-involved, opioid-injecting women: Drug, set, and setting.

Authors:  Janna Ataiants; Alexis M Roth; Silvana Mazzella; Stephen E Lankenau
Journal:  Int J Drug Policy       Date:  2020-02-18

9.  A scoping review of factors that influence opioid overdose prevention for justice-involved populations.

Authors:  Christine E Grella; Erika Ostlie; Christy K Scott; Michael L Dennis; John Carnevale; Dennis P Watson
Journal:  Subst Abuse Treat Prev Policy       Date:  2021-02-22

10.  Multiple Victimizations and Overdose Among Women With a History of Illicit Drug Use.

Authors:  Janna Ataiants; Silvana Mazzella; Alexis M Roth; Lucy F Robinson; Randall L Sell; Stephen E Lankenau
Journal:  J Interpers Violence       Date:  2020-06-14
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.